• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Jennifer Doudna wins 2020 Nobel Prize in Chemistry

Bioengineer by Bioengineer
October 7, 2020
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: UC Berkeley

Biochemist Jennifer Doudna, a professor at UC Berkeley and faculty scientist at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab), is co-winner of the 2020 Nobel Prize in Chemistry for “the development of a method for genome editing.”

She shares the Nobel Prize with co-discoverer Emmanuelle Charpentier, who currently serves as the scientific and managing director of the Max Planck Unit for the Science of Pathogens in Berlin. Together, they form the first all-woman research team to win a Nobel Prize.

“On behalf of the Berkeley Lab community, I extend my warmest congratulations to Jennifer Doudna for receiving the Nobel Prize in Chemistry. She is an exceptional scientist, and her groundbreaking research will inspire the next generation of scientists to take on challenges that both push the boundaries of knowledge and benefit humanity,” said Berkeley Lab Director Mike Witherell.

The discovery of the CRISPR-Cas9 genetic engineering technology has radically changed genomics research. This genome-editing technology enables scientists to change or remove genes quickly, with a precision only dreamed of just a few years ago. Labs worldwide have redirected the course of their research to incorporate this new tool, with huge implications across biology, agriculture, and medicine.

Doudna is a faculty scientist in Berkeley Lab’s Molecular Biophysics and Integrated Bioimaging Division; a professor of molecular and cell biology, and chemistry, at UC Berkeley; and an investigator at the Howard Hughes Medical Institute.

Foundational Berkeley Lab research

Doudna’s interest in gene editing can be traced to her research as a doctoral student at Harvard Medical School, when she designed a self-replicating RNA. As a research fellow at the University of Colorado at Boulder, she began crystallizing RNA so that she could study its structure and understand the physical basis of catalysis. While on the faculty at Yale University, she continued her study of catalytic RNA. When she joined UC Berkeley and Berkeley Lab in 2002, she pursued her interest in how RNA molecules decide what genetic information gets disseminated in cells.

In 2008, Doudna’s nascent research on CRISPR RNA strands and the Cas1 protein was funded by a U.S. Department of Energy (DOE) Laboratory Directed Research and Development (LDRD) Program award through her Berkeley Lab affiliation. Established by Congress in 1991, the LDRD program has helped the U.S. remain at the forefront of technology through the innovative, multidisciplinary research of the DOE national labs.

Building upon findings from this early work and other investigations, in 2012, Doudna and Charpentier’s research team detailed the underlying mechanisms of the CRISPR-Cas9 system – a component of the bacterial immune system that defends against invading viruses – and explained how it can be programmed to cut DNA at a target sequence. This seminal work was published in the journal Science.

Today, Doudna and Charpentier’s Nobel Prize-winning CRISPR-Cas9 technology is the basis of many promising medical technologies, including tools to diagnose and treat disease, and has many applications for the development of improved crops, biofuels, and bioproducts.

With Doudna’s award, Berkeley Lab scientists and research have now been recognized with 14 Nobel Prizes.

For more details about the Nobel Prize, see the UC Berkeley news release.

Additional information:

* Nobel announcement

* History of Nobel Prizes at Berkeley Lab/

Founded in 1931 on the belief that the biggest scientific challenges are best addressed by teams, Lawrence Berkeley National Laboratory (https://www.lbl.gov/) and its scientists have been recognized with 14 Nobel Prizes. Today, Berkeley Lab researchers develop sustainable energy and environmental solutions, create useful new materials, advance the frontiers of computing, and probe the mysteries of life, matter, and the universe. Scientists from around the world rely on the Lab’s facilities for their own discovery science. Berkeley Lab is a multiprogram national laboratory, managed by the University of California for the U.S. Department of Energy’s Office of Science.

DOE’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit energy.gov/science.

Media Contact
Laurel Kellner
[email protected]

Original Source

https://newscenter.lbl.gov/2020/10/07/doudna-wins-nobel-prize-chemistry/

Tags: BiochemistryBiologyBiomedical/Environmental/Chemical EngineeringBiotechnologyGene TherapyGenesMicrobiologyMolecular Biology
Share13Tweet8Share2ShareShareShare2

Related Posts

Diastereodivergent Routes to Multi-Substituted Cycloalkanes

Diastereodivergent Routes to Multi-Substituted Cycloalkanes

August 5, 2025
Spatial Metabolomics Reveals Lasting Stroke Brain Changes

Spatial Metabolomics Reveals Lasting Stroke Brain Changes

August 5, 2025

Rethinking Resilience in Post-Nuclear Food Trade Recovery

August 5, 2025

Brain Networks Activate Differently Listening to Parents vs Strangers

August 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Neuropsychiatric Risks Linked to COVID-19 Revealed

    71 shares
    Share 28 Tweet 18
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    46 shares
    Share 18 Tweet 12
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Diastereodivergent Routes to Multi-Substituted Cycloalkanes

Spatial Metabolomics Reveals Lasting Stroke Brain Changes

Rethinking Resilience in Post-Nuclear Food Trade Recovery

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.